Hyper-targeted small molecules for reprogramming immune cells to treat disease

MorphImmune, Inc. addresses significant unmet medical needs by selectively targeting
and reprogramming dysregulated immune cells that cause or promote disease


connect with us

Do you have any questions or just want to connect? We would love to hear from you.